» Articles » PMID: 15489893

ST18 is a Breast Cancer Tumor Suppressor Gene at Human Chromosome 8q11.2

Overview
Journal Oncogene
Date 2004 Oct 19
PMID 15489893
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

We have identified a gene, ST18 (suppression of tumorigenicity 18, breast carcinoma, zinc-finger protein), within a frequent imbalanced region of chromosome 8q11 as a breast cancer tumor suppressor gene. The ST18 gene encodes a zinc-finger DNA-binding protein with six fingers of the C2HC type (configuration Cys-X5-Cys-X12-His-X4-Cys) and an SMC domain. ST18 has the potential to act as transcriptional regulator. ST18 is expressed in a number of normal tissues including mammary epithelial cells although the level of expression is quite low. In breast cancer cell lines and the majority of primary breast tumors, ST18 mRNA is significantly downregulated. A 160 bp region within the promoter of the ST18 gene is hypermethylated in about 80% of the breast cancer samples and in the majority of breast cancer cell lines. The strong correlation between ST18 promoter hypermethylation and loss of ST18 expression in tumor cells suggests that this epigenetic mechanism is responsible for tumor-specific downregulation. We further show that ectopic ST18 expression in MCF-7 breast cancer cells strongly inhibits colony formation in soft agar and the formation of tumors in a xenograft mouse model.

Citing Articles

St18 specifies globus pallidus projection neuron identity in MGE lineage.

Nunnelly L, Campbell M, Lee D, Dummer P, Gu G, Menon V Nat Commun. 2022; 13(1):7735.

PMID: 36517477 PMC: 9751150. DOI: 10.1038/s41467-022-35518-5.


Whole-Exome Sequencing Identifies Pathogenic Germline Variants in Patients with Lynch-Like Syndrome.

Dos Santos W, de Andrade E, Garcia F, Campacci N, Sabato C, Melendez M Cancers (Basel). 2022; 14(17).

PMID: 36077770 PMC: 9454535. DOI: 10.3390/cancers14174233.


Whole exome analysis reveals the genomic profiling related to chemo-resistance in Chinese population with limited-disease small cell lung cancer.

Yu J, Zhao S, Su Z, Song C, Wu L, Wang J Cancer Med. 2022; 12(2):1035-1050.

PMID: 35735600 PMC: 9883427. DOI: 10.1002/cam4.4950.


Identification of Prognostic Biomarkers for Bladder Cancer Based on DNA Methylation Profile.

Zhang S, Zhang J, Zhang Q, Liang Y, Du Y, Wang G Front Cell Dev Biol. 2022; 9:817086.

PMID: 35174173 PMC: 8841402. DOI: 10.3389/fcell.2021.817086.


Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression.

Stratmann S, Yones S, Garbulowski M, Sun J, Skaftason A, Mayrhofer M Blood Adv. 2021; 6(1):152-164.

PMID: 34619772 PMC: 8753201. DOI: 10.1182/bloodadvances.2021004962.